All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Introducing
Now you can personalise
your Lymphoma Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Bookmark this article
Registration is now open for the CALYM / IMAGINE workshop which will take place on the 19th January 2018 in Paris, France. The workshop has been organized by the CALYM Carnot Institute and the IMAGINE Associated Carnot Institute to address the topic of “translating next generation genomics in precision medicine”.
A provisional program has been released that includes sessions on somatic and germline genetics, identification of therapeutic targets and biomarkers in lymphoma using new genomic technologies (Crispr/Cas9), and a round table discussion. The workshop aims to bring together academic and industrial specialists to discuss genetic advances in the innovation of therapies in lymphoma and immune deficiencies, and is co-chaired by Olivier Hermine (IMAGINE) and Gilles Salles (CALYM)
To register for the workshop visit the website here. Registration is open until 22nd December 2017.
Understanding your specialty helps us to deliver the most relevant and engaging content.
Please spare a moment to share yours.
Please select or type your specialty
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox